NobleBlocks
Public

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

Published in EBioMedicine • Sep 1, 2019
NobleIDNI0P10W23R38S94
Authors:
LaTonya J. Hickson
,
Larissa G.P. Langhi Prata
,
Shane A. Bobart
Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!